Cargando…

Novel dose–response analyses of treprostinil in pulmonary arterial hypertension and its effects on six-minute walk distance and hospitalizations

Treprostinil is a prostacyclin analogue approved for the treatment of pulmonary arterial hypertension. Apart from the inhaled formulation, there is neither a target dose nor a ceiling dose to guide clinicians using treprostinil; doses are individualized for each patient based upon tolerability and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramani, Gautam, Cassady, Steven, Shen, Eric, Broderick, Meredith, Wasik, Allie, Sui, Qun, Nelsen, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826281/ https://www.ncbi.nlm.nih.gov/pubmed/35154662 http://dx.doi.org/10.1177/2045894020923956

Ejemplares similares

Dosing characteristics of oral treprostinil in real-world clinical practice
por: Balasubramanian, Vijay P., et al.
Publicado: (2018)

Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting
por: Balasubramanian, Vijay P., et al.
Publicado: (2022)

Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily
por: Shapiro, Shelley, et al.
Publicado: (2021)

Fick principle and exercise pulmonary hemodynamic determinants of the six-minute walk distance in pulmonary hypertension
por: Joseph, Phillip, et al.
Publicado: (2020)

Treprostinil for pulmonary hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2008)

Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studies
por: Tonelli, Adriano R., et al.
Publicado: (2020)

Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension
por: Khan, Akram, et al.
Publicado: (2022)

Prognostic value of six-minute walk distance at a South American pulmonary hypertension referral center
por: Costa, Gabriela O.S., et al.
Publicado: (2020)

Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics
por: White, R. James, et al.
Publicado: (2020)

Six-minute walk test in pulmonary arterial hypertension
por: Demir, Rengin, et al.
Publicado: (2015)

Six minute walking distance in kyphoscoliosis patients with chronic respiratory failure
por: Karakurt, Zuhal, et al.
Publicado: (2010)

Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2013)

A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinil
por: Zwicke, Diane L., et al.
Publicado: (2021)

Impaired Economy of Gait and Decreased Six-Minute Walk Distance in Parkinson's Disease
por: Katzel, Leslie I., et al.
Publicado: (2012)

Overweight-mortality paradox and impact of six-minute walk distance in lung transplantation
por: Chaikriangkrai, Kongkiat, et al.
Publicado: (2015)

Alternatives to the Six-Minute Walk Test in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2014)

Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil
por: Kingrey, John F., et al.
Publicado: (2023)

Inhaled treprostinil and pulmonary arterial hypertension
por: Nadler, Samuel T, et al.
Publicado: (2010)

Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension
por: Chen, Hubert, et al.
Publicado: (2013)

Reference equations for the six-minute walk distance based on a Brazilian multicenter study
por: Britto, Raquel R., et al.
Publicado: (2013)

Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD
por: Andrianopoulos, Vasileios, et al.
Publicado: (2014)

Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil
por: Mancuzo, Eliane Viana, et al.
Publicado: (2018)

Usefulness of the desaturation–distance ratio from the six-minute walk test for patients with COPD
por: Fujimoto, Yukari, et al.
Publicado: (2017)

Six-minute walking distance in healthy Chinese people older than 60 years
por: Zou, He, et al.
Publicado: (2020)

Determinants of Six-Minute Walk Distance in Idiopathic Pulmonary Fibrosis and Idiopathic Pleuroparenchymal Fibroelastosis
por: Sato, Naofumi, et al.
Publicado: (2022)

The correlation between six-minute walking distance and maximum phonation time in healthy adults
por: Santausa, Febrian Mulya, et al.
Publicado: (2023)

Determinants of distance walked during the six-minute walk test in patients undergoing cardiac surgery at hospital discharge
por: Oliveira, Géssica Uruga, et al.
Publicado: (2014)

Six-Minute Walk Test in Evaluation of Children with Pulmonary Arterial Hypertension
por: Zuk, Malgorzata, et al.
Publicado: (2017)

Lung function in relation to six-minute walk test in pulmonary hypertension
por: Farkhooy, Amir, et al.
Publicado: (2020)

A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration
por: Kumar, Parag, et al.
Publicado: (2016)

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
por: Bourge, Robert C, et al.
Publicado: (2013)

Reference Value for the Distance Walked in the Six-Minute Walk Test in Obese Brazilian Men in the Preoperative Period of Bariatric Surgery
por: Luchesa, Cesar Antonio, et al.
Publicado: (2021)

Changes in six-minute walking distance during pulmonary rehabilitation in patients with COPD and in healthy subjects
por: Ben Cheikh Rejbi, Imen, et al.
Publicado: (2010)

Can the six-minute walk distance predict the occurrence of acute exacerbations of COPD in patients in Brazil?
por: Morakami, Fernanda Kazmierski, et al.
Publicado: (2017)

Six-Minute Walk Distance in Breast Cancer Survivors—A Systematic Review with Meta-Analysis
por: But-Hadzic, Jasna, et al.
Publicado: (2021)

Determinants and Prediction Equations of Six-Minute Walk Test Distance Immediately After Cardiac Surgery
por: Radi, Basuni, et al.
Publicado: (2021)

Maximal Cardiac Output Determines 6 Minutes Walking Distance in Pulmonary Hypertension
por: Deboeck, Gaël, et al.
Publicado: (2014)

Effect of PAH Specific Therapy on Pulmonary Hemodynamics and Six-Minute Walk Distance in Portopulmonary Hypertension: A Systematic Review and Meta-Analysis
por: Faisal, Muhammad, et al.
Publicado: (2014)

Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
por: Chapman, Richard W., et al.
Publicado: (2021)

Implantable system for treprostinil: a real-world patient experience study
por: Shapiro, Shelley, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7vc652vc36lob8vnt94i6nhmhh